Why breast cancer that spreads to the brain resists treatment
Original title: Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of the science so far, not a new treatment.
The short version
Doctors reviewed why drugs often stop working once breast cancer reaches the brain.
What was studied. This is a review paper, not a new study. The authors looked back at lab work, patient studies, and gene studies of breast cancer that spread to the brain.
What they found. Brain spread affects 15-30% of people whose breast cancer has spread. It is more common with HER2-positive or triple-negative breast cancer, and survival is often under 12 months. The review says the brain acts like a shield. Its blood vessels push many drugs back out, and nearby brain cells help the tumor stay alive.
What this means, and what it doesn't
What it could mean: This may help explain something many people live with. A drug can control cancer in the body but not in the brain. The authors point to drugs built to reach the brain, and to treatments used in pairs. Those ideas are still being studied.
What it doesn't mean: This does not mean a new treatment is here. It is a summary of where the science stands, not a new result in people. Nothing in it was tested as a new therapy. None of these ideas are ready for your care today, and this is not a cure.
Source: PubMed, August 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.